Pavmed Inc. (NSDQ:PAVM) said today that it closed its offer to exchange two Series W warrants for a single Z warrant.
Approximately 10,151,682 Series W warrants were tendered and not withdrawn, which represents 96.4% of outstanding Series W warrants, the New York-based company said.
Get the full story at our sister site, Drug Delivery Business News.
The post Pavmed closes warrant exchange offer appeared first on MassDevice.